Discover NobivacĀ® nxt-level protection

NobivacĀ® NXT (next) are the first and only companion animal vaccines to use revolutionary RNA particle technology

The NobivacĀ® NXT advantage

See how our groundbreaking RNA particle technology delivers NXT-level immunity to your patients

Benefits of NobivacĀ® NXT-level protection

Smaller
dose

A low-volume 0.5-mL dose for a more gentle vaccine experience

No extraneous
material

NobivacĀ® NXT-level protection in a preservative-free, adjuvant-free, thimerosal-free formulation

Targeted and
efficient

Delivers the desired viral sequence to dendritic cells for an enhanced, precise immune response

Safety and efficacy
without compromise

Self-amplification triggers a robust antibody and cellular immune response without the use of an adjuvant or live organisms

NobivacĀ® NXT level immunity

  • Deliver an unparalleled combination of optimal safety and robust efficacy
  • NobivacĀ® NXT-level RNA particle technology enhances the body’s natural processes to stimulate comprehensive immunity
  • Adjuvant-free, preservative-free, low-volume, 0.5-mL dose
  • Total peace of mind for pet owners and you

Revolutionary RNA particle technology

  • Delivers the RNA sequence of a pathogen’s specific gene of interest (GOI) in a targeted way to the dendritic cell
  • The GOI is unpackaged and, for a limited time, makes multiple copies of itself
  • The copies of the GOI are translated into large amounts of antigen, which stimulates a broad and balanced immune response

Related Products

NobivacĀ® NXT FeLV

First and only non-adjuvanted feline leukemia virus (FeLV) vaccine built on RNA particle technology

NobivacĀ® NXT Canine Flu H3N2

First and only canine flu vaccine built on RNA particle technology